Focused Alpha’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-32,421
Closed -$1.31M – 274
2026
Q1
$1.31M Buy
+32,421
New +$1.21M 0.4% 47

Other funds holding CORT

Focused Alpha's CORT Position: Q2 2026 in Review

Focused Alpha sold out of Corcept Therapeutics (CORT) in Q2 2026, closing a stake of 32,421 shares — an estimated $1.31M sold.

Focused Alpha first reported a position in CORT in Q1 2026 and held it in 1 quarter. The position peaked at $1.31M in Q1 2026. 425 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Focused Alpha reported no remaining Corcept Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Focused Alpha sold 32,421 Corcept Therapeutics shares in Q2 2026, an estimated $1.31M.
  • Focused Alpha first reported a position in Corcept Therapeutics in Q1 2026 and held it in 1 quarter.
  • Focused Alpha's Corcept Therapeutics position peaked at $1.31M in Q1 2026.
  • 425 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Focused Alpha's 13F filing for Q2 2026, filed 7 Aug 2026.